PRTG Portage Biotech Inc
423
$0.3057
$0.0347
(12.80%)
| Watchers | 423 |
| 52-Wk Low | $0.1999 |
| 52-Wk High | $4.40 |
| Market Cap | $3.61M |
| Volume | 279,874.00 |
| 52-Wk High | $4.40 |
| 52-Wk Low | $0.1999 |
Portage Biotech completes monetization of Intensity Therapeutics sharesThe Fly • about 1 month ago
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Share to Feed
Company generated approximately $2.8M of non-dilutive funding to extend cash runwayWESTPORT, Conn., March 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage...
Portage Biotech (NASDAQ:PRTG Get Free Report) and Southwestern Energy (NYSE:SWN Get Free Report) are both medical companies, but which is the better stock? We will contrast the two...
Company focused on adenosine platform clinical developmentWESTPORT, Conn., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG) ( Portage or the Company ), a clinical-stage...
Portage Biotech to halt iNKT drug program, cut workforce...
Prioritize the adenosine clinical candidates iNKT clinical development paused to focus resourcesCompany will evaluate range of strategic options WESTPORT, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE...